ArticleBMC cardiovascular disorders2025
Diffuse Active Myocarditis in a Teenager with Duchenne Muscular Dystrophy - a case report.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cardiac Safety Outcomes in Delandistrogene Moxeparvovec Clinical Trials for Duchenne Muscular Dystrophy with Up to 5 Years of Follow-up.Cardiology and therapy · 2026Article
- Echocardiography in duchenne muscular dystrophy: a call for consistency and standardisation of reporting.Echo research and practice · 2026Review
- Unravelling the Complications of Dilated Cardiomyopathy in Duchenne Muscular Dystrophy: From Molecular Pathways to Disease Management.Cardiovascular & hematological disorders drug targets · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDuchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by mutations in the dystrophin gene. These mutations result in the absence or reduced levels of dystrophin protein, leading to progressive skeletal and cardiac muscle deterioration. Cardiomyopathy is almost universally present in patients with DMD who survive into their third decade of life. The clinical onset of cardiac dysfunction is often asymptomatic and typically identified during routine evaluations. Acute deterioration of cardiac function in DMD patients is rarely reported in the medical literature. CASE PRESENTATION: We report the case of a 13-year-old boy with DMD and preserved left ventricular (LV) function who presented with severe retrosternal chest pain and electrocardiographic (ECG) abnormalities. Laboratory testing revealed significantly elevated troponin levels, though coronary CT angiography (CTA) was normal. Cardiac magnetic resonance imaging (CMR) confirmed diffuse active myocarditis, demonstrating inflammation and fibrosis involving both the septal and lateral walls-a pattern of fibrosis atypical for Duchenne cardiomyopathy.
conclusionDiffuse active myocardial injury with the pattern of active myocarditis is one of the causes of rapid deterioration of LV dysfunction in Duchenne cardiomyopathy and can be detected by CMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.